Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume $0.97 +0.01 (+1.04%) Closing price 03:59 PM EasternExtended Trading$1.00 +0.03 (+3.61%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Short Interest DataLexaria Bioscience (LEXX) has a short interest of 588,100 shares, representing 3.26% of the float (the number of shares available for trading by the public). This marks a 13.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.4, indicating that it would take 5.4 days of the average trading volume of 159,656 shares to cover all short positions.Current Short Interest588,100 sharesPrevious Short Interest520,200 sharesChange Vs. Previous Month+13.05%Dollar Volume Sold Short$682,196.00Short Interest Ratio5.4 Days to CoverLast Record DateApril 30, 2025Outstanding Shares17,559,000 sharesFloat Size18,060,000 sharesShort Percent of Float3.26%Today's Trading Volume56,893 sharesAverage Trading Volume159,656 sharesToday's Volume Vs. Average36% Short Selling Lexaria Bioscience? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLEXX Short Interest Over TimeLEXX Days to Cover Over TimeLEXX Percentage of Float Shorted Over Time Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025588,100 shares $682,196.00 +13.1%3.3%5.4 $1.16 4/15/2025520,200 shares $743,886.00 -23.5%3.2%5 $1.43 3/31/2025679,900 shares $1.16 million +30.2%4.2%4.5 $1.71 3/15/2025522,200 shares $704,970.00 -5.1%3.2%3.3 $1.35 2/28/2025550,200 shares $808,794.00 +2.0%3.4%3.1 $1.47 2/15/2025539,400 shares $863,040.00 -11.6%3.3%3 $1.60 1/31/2025610,400 shares $1.08 million -17.4%3.8%3.3 $1.77 1/15/2025739,000 shares $1.40 million +43.6%4.5%3.8 $1.90 12/31/2024514,700 shares $1.08 million +3.1%3.2%3.5 $2.10 12/15/2024499,300 shares $1.12 million +67.4%3.1%3.5 $2.24 Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024298,200 shares $620,256.00 -12.9%1.8%2.2 $2.08 11/15/2024342,400 shares $688,224.00 +23.6%2.1%2.4 $2.01 10/31/2024277,100 shares $595,765.00 +0.5%1.7%1.8 $2.15 10/15/2024275,700 shares $791,259.00 -11.4%1.7%1.7 $2.87 9/30/2024311,100 shares $948,855.00 -2.0%2.1%1.8 $3.05 9/15/2024317,500 shares $1.09 million +31.4%2.2%1.8 $3.43 8/31/2024241,700 shares $945,047.00 +54.5%1.7%1.3 $3.91 8/15/2024156,400 shares $492,660.00 -27.8%1.1%0.7 $3.15 7/31/2024216,500 shares $885,485.00 +36.4%1.5%1 $4.09 7/15/2024158,700 shares $461,817.00 No Change1.1%0.8 $2.91 6/30/2024158,700 shares $441,186.00 +3.7%1.3%0.7 $2.78 6/15/2024153,000 shares $472,770.00 -25.7%1.2%0.6 $3.09 5/31/2024205,900 shares $800,951.00 +30.7%1.7%0.5 $3.89 5/15/2024157,500 shares $485,100.00 -38.8%1.4%0.3 $3.08 4/30/2024257,200 shares $794,748.00 -41.0%2.3%0.5 $3.09 4/15/2024435,600 shares $866,844.00 -11.2%3.7%0.9 $1.99 3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63 3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90 2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45 2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36 1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49 1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51 12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25 12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27 11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50 11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34 10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38 10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92 9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00 9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87Man who predicted $100K Bitcoin sees a huge run coming for another coin … (Ad)Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.There's another coin he thinks could do even better. 8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05 8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11 7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83 7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83 6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73 6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69 5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74 5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72 4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09 4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18 3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72 3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71 2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03 2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97 1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21 1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77 12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46 12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79 11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96 11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41 10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21 10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11 9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45 9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93 8/31/2022334,400 shares $989,824.00 -0.1%6.2%6.2 $2.96 8/15/2022334,600 shares $1.07 million -0.1%6.2%5.6 $3.20 7/31/2022334,900 shares $904,230.00 +15.9%6.2%5.6 $2.70 7/15/2022288,900 shares $826,254.00 -33.7%5.4%3.9 $2.86 6/30/2022435,900 shares $1.30 million +3.7%8.1%0.5 $2.98 6/15/2022420,400 shares $941,696.00 +15.7%7.8%0.5 $2.24 5/31/2022363,500 shares $745,175.00 +34.1%6.8%0.4 $2.05 5/15/2022271,100 shares $555,755.00 -8.8%5.0%0.3 $2.05 4/30/2022297,300 shares $826,494.00 +14.2%5.5%0.3 $2.78 4/15/2022260,400 shares $997,332.00 -2.1%4.8%0.3 $3.83 3/31/2022266,100 shares $878,130.00 -3.8%5.0%4.6 $3.30 3/15/2022276,700 shares $868,838.00 -5.6%5.1%3.5 $3.14 2/28/2022293,100 shares $1.04 million -12.4%5.5%1 $3.55 2/15/2022334,700 shares $1.31 million -11.8%6.2%1.1 $3.90 1/31/2022379,600 shares $1.52 million +15.5%14.0%1.2 $4.00 1/15/2022328,800 shares $1.52 million -7.1%12.1%1.1 $4.61 12/31/2021353,800 shares $1.43 million -13.8%13.3%1.2 $4.03 12/15/2021410,300 shares $1.84 million +26.8%15.4%1.3 $4.49 11/30/2021323,500 shares $1.71 million -9.0%12.2%1.1 $5.30 11/15/2021355,300 shares $2.29 million -1.9%14.8%2.2 $6.44 10/29/2021362,200 shares $2.24 million -3.2%15.1%2.1 $6.19 10/15/2021374,000 shares $2.56 million +10.3%15.6%1.8 $6.84 9/30/2021339,000 shares $2.12 million -5.5%14.1%0.3 $6.26 9/15/2021358,900 shares $2.23 million +22.4%15.0%0.3 $6.21 8/31/2021293,300 shares $1.82 million -5.2%12.2%0.3 $6.22 8/13/2021309,300 shares $1.70 million No Change12.9%0.3 $5.51AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution LEXX Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 588,100 shares of LEXX short. 3.26% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest. What is a good short interest ratio for Lexaria Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEXX shares currently have a short interest ratio of 5.0. Learn More on Lexaria Bioscience's short interest ratio. What is a good short interest percentage for Lexaria Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.26% of Lexaria Bioscience's floating shares are currently sold short. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 588,100 shares, an increase of 13.1% from the previous total of 520,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lexaria Bioscience's float size? Lexaria Bioscience currently has issued a total of 17,559,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 18,060,000 shares. How does Lexaria Bioscience's short interest compare to its competitors? 3.26% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lexaria Bioscience: Genenta Science S.p.A. (0.02%), Exicure, Inc. (1.15%), CytomX Therapeutics, Inc. (12.08%), Telomir Pharmaceuticals, Inc. (12.93%), ESSA Pharma Inc. (1.60%), Sutro Biopharma, Inc. (6.32%), Pyxis Oncology, Inc. (16.42%), Jasper Therapeutics, Inc. (14.56%), IGM Biosciences, Inc. (5.32%), MediciNova, Inc. (0.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Genenta Science Short Squeeze Exicure Short Squeeze CytomX Therapeutics Short Squeeze Telomir Pharmaceuticals Short Squeeze ESSA Pharma Short Squeeze Sutro Biopharma Short Squeeze Pyxis Oncology Short Squeeze Jasper Therapeutics Short Squeeze IGM Biosciences Short Squeeze MediciNova Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
